The disruption in insulin signalling may increase the risk factor of CVS disorders (arteriosclerosis, cardiomyopathy, dyslipidemia, coronary artery disease, and hypertension) and CNS disorders (AD, depression, PD, Schizophrenia, psychosis and epilepsy) [60-65]. This evidence concerns the gene INS and hypertensive disorder.